Skip to content

AI Strategy, Applied.

A curated archive of measured commentary on AI adoption, governance, and enterprise transformation — written for leaders who want clearer decisions, not louder noise.

Filter:

Recent Strategic Commentary

3 total entries
Biotech

Novartis Attributes Discovery of Novel Cancer Inhibitor to its 'Genesis' Generative Biology Platform

Novartis revealed that its proprietary AI, 'Genesis', independently hypothesized, simulated, and identified a promising new molecule for treating aggressive forms of lung cancer, a process that took only 45 days. This breakthrough validates massive R&D investment in AI and fundamentally changes the economics and speed of drug discovery, creating a new competitive benchmark for the entire pharmaceutical and biotech industries.

3 min read
Supply Chain

Maersk Unveils 'Odyssey AI': The First Fully Autonomous Supply Chain Orchestrator

Maersk's new AI system is now managing 30% of its Pacific shipping routes without human intervention, dynamically rerouting ships and adjusting logistics based on real-time data from weather to port congestion. This signals a major shift from AI as an analytical tool to a fully autonomous operational core, forcing competitors to re-evaluate their own AI roadmaps and readiness for hands-off operations.

3 min read

Deeper Strategic Readiness

Beyond individual perspectives, the AI Readiness Assessment provides a structural framework for evaluating your organization's position.